The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Report of adverse events of special interest (AESIs) for sintilimab plus a bevacizumab biosimilar (IBI305) in unresectable hepatocellular carcinoma.
 
Zhenggang Ren
Consulting or Advisory Role - AstraZeneca; Merck Sharp & Dohme; Roche
 
Jianming Xu
No Relationships to Disclose
 
Yuxian Bai
No Relationships to Disclose
 
Aibing Xu
No Relationships to Disclose
 
Shundong Cang
No Relationships to Disclose
 
Chengyou Du
No Relationships to Disclose
 
Baorui Liu
No Relationships to Disclose
 
Qiu Li
No Relationships to Disclose
 
Yinying Lu
No Relationships to Disclose
 
Yajin Chen
No Relationships to Disclose
 
Guoliang Shao
No Relationships to Disclose
 
Yabing Guo
No Relationships to Disclose
 
Zhendong Chen
No Relationships to Disclose
 
Jia Fan
No Relationships to Disclose